Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics.
about
Plasmid-determined AmpC-type beta-lactamases.Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniaeEnterobacter spp.: pathogens poised to flourish at the turn of the centuryThe Development of Selective Inhibitors of NagZ: Increased Susceptibility of Gram-Negative Bacteria to β-LactamsampG gene of Pseudomonas aeruginosa and its role in β-lactamase expressionIdentification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosisIn vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistanceGenetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenesEfficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.Beta-lactam antibiotics: from antibiosis to resistance and bacteriologyAbility of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzymeEmergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan.Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19.Guidelines on antimicrobial chemotherapy for prevention and treatment of infections in the intensive care unit.Tandem amplification of a 28-kilobase region from the Yersinia enterocolitica chromosome containing the blaA genePlasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens.Hospital-acquired infections: diseases with increasingly limited therapies.Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 beta-lactamase (LAT-2).Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice.Diverse potential of beta-lactamase inhibitors to induce class I enzymes.Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facilityIn vitro evaluation of BRL 42715, a novel beta-lactamase inhibitorDiagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coliDecimal assay for additivity of drugs permits delineation of synergy and antagonismResistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.Comparative activity of several antimicrobial agents against nosocomial Gram-negative rods isolated across Canada.In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrumResistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France.Preliminary characterization of a food-borne multiple-antibiotic-resistant Salmonella typhimurium strain.In vitro antibacterial activity of MGDG-palmitoyl from Oscillatoria acuminata NTAPC05 against extended-spectrum β-lactamase producers.Carbapenems in the USA: focus on doripenem.An epidemic of plasmids? Dissemination of extended-spectrum cephalosporinases among Salmonella and other Enterobacteriaceae.Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production.More extended-spectrum beta-lactamasesAmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.In vitro activities of ceftazidime-avibactam and aztreonam-avibactam against 372 Gram-negative bacilli collected in 2011 and 2012 from 11 teaching hospitals in China.
P2860
Q24535748-C0DD82C8-38EE-466B-9CE4-48D26FA2573FQ24674937-F560F4F9-AC5F-4762-9768-442225EDDBC9Q24683746-C2720C7D-8C53-46C7-BDFB-E67CFE8A5023Q27679877-FAAD7E07-7817-448D-892C-E14E5BD71915Q28493038-9299FC90-981E-4590-88A5-671223769516Q31991562-D5142E4C-43C8-4D48-85A6-686812B38C3AQ33690950-F371803F-E6A4-4568-80C7-028BAF3AE86FQ33747222-A7956B80-091F-4EF5-9FA3-67FA30C2303BQ33768904-A40D3980-11F0-49B8-9E6B-CEC0285EEF5CQ33938172-FEA3AE03-918B-4D12-93C2-4929D29B398CQ33951933-384A7024-D5D1-4F12-8294-1D566D907059Q33970955-66B1ED7A-E0D9-4E56-859B-6A34EFB04712Q33982677-16004CEC-95F2-42C1-ADD5-5ABE535F0893Q34195633-97BAF656-C8C2-48BC-A253-B01FB9D52FDBQ34352060-4DAD23C2-7AF4-478D-AFBA-734BF9A2855EQ34589960-E1BFC482-DFA0-4832-B33C-C068DCD5A9CBQ34823470-3527A4C3-EABC-4898-A907-0A0989F826BFQ35112955-3AC35E45-9A7A-4B47-B531-6E347A1D832EQ35113057-F925B97A-AC3B-4CB5-8BAE-2A64B71A7771Q35119621-C8A6F062-5A8C-4C34-9C09-89D3164D0D7DQ35125797-26F312E8-05D2-4082-95F0-382ED5272F29Q35168955-9AF9B8AC-DF1F-4D85-B67D-1A64F552DB26Q35246938-CD321DCA-3C41-46C2-A9ED-7E0F0076681FQ35281765-EABB29D5-F178-49B6-91B3-A8703A5A24D5Q35350158-76804E3B-29AA-4A90-8239-E03988274902Q35356144-51BE11BD-13CA-45D8-A193-5D4C72219292Q35360336-79A4CB9F-6DF8-49C8-9320-2AEDB542B5D6Q35808612-AA3AEC95-6F40-451A-8F1E-CB8BC7AC2242Q35814714-C71B498B-044B-4FD3-92B5-7A2A27F51735Q35816718-4194D886-CDA3-4A91-AFCC-9F23FB682628Q35884688-8F331502-0A51-4655-ACCD-2894E305BB24Q35893975-9DC60F09-1446-4DA1-B4ED-B6F9E25DC28AQ36073386-8708E088-AEB2-4861-82AF-DA4F9A931F12Q36335143-E2EEE726-A834-4AC8-AF4D-BFEB37B47EEAQ36960048-5045663C-6BE6-47B8-B1E7-85A9FCFCF631Q37037740-51DB32FF-56BC-4E40-9E90-AFBE3089AAB0Q37119379-90BBE3FB-592F-4960-A73E-C28363970341Q37520309-5CFE522A-830E-4634-8EC0-5E38FA1C45D9Q37568397-E8BFA214-EB5B-495F-9E90-52DCA31B1DC7Q37643595-C6BE0F87-464F-4BD6-9C13-6D0730C59414
P2860
Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Chromosomal cephalosporinases ...... newer beta-lactam antibiotics.
@en
Chromosomal cephalosporinases ...... newer beta-lactam antibiotics.
@nl
type
label
Chromosomal cephalosporinases ...... newer beta-lactam antibiotics.
@en
Chromosomal cephalosporinases ...... newer beta-lactam antibiotics.
@nl
prefLabel
Chromosomal cephalosporinases ...... newer beta-lactam antibiotics.
@en
Chromosomal cephalosporinases ...... newer beta-lactam antibiotics.
@nl
P1476
Chromosomal cephalosporinases ...... newer beta-lactam antibiotics.
@en
P2093
Sanders CC
P304
P356
10.1146/ANNUREV.MI.41.100187.003041
P577
1987-01-01T00:00:00Z